CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that ...
Wyden and Brown pointed to CVS (CVS) and Cigna’s (CI) manufacturing subsidiaries, Cordavis and Quallent Pharmaceuticals. Established to produce biosimilars against AbbVie’s (ABBV) Humira in ...
CVS Caremark said in a statement that it's drugmakers who are increasing the prices of drugs rather than PBMs. Cigna Chief Legal Officer Andrea Nelson said in a statement that the FTC's lawsuit is ...
The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.
FTC’s lawsuit against PBMs puts UnitedHealth, CVS, and Cigna stocks in focus for investors seeking stability. Cigna could see more price movement than UNH and CVS, thanks to its focused ...
following similar moves by rivals Cigna (NYSE:CI) and CVS Health (NYSE:CVS). However, the company added that it will devise a path to offer coverage for Humira until the biosimilars win the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback